Wilson Sonsini Goodrich & Rosati advised Denali Therapeutics Inc. on the transaction. Denali Therapeutics (Nasdaq: DNLI) announced that it entered into a securities purchase agreement with...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Sana Biotechnology on the offering, and Cooley advised the underwriters. Sana Biotechnology, Inc. (Nasdaq: SANA) announced the closing of its...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Tenaya Therapeutics on the transaction, and Davis Polk & Wardwell advised the underwriters. Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Edgewise Therapeutics on the transaction, and Cooley represented the underwriters. Edgewise Therapeutics, Inc. (“Edgewise”) (NASDAQ: EWTX) announced the pricing of an underwritten...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Assembly Bio on the transaction, and Ropes & Gray advised Gilead Sciences, Inc. Assembly Biosciences (Nasdaq: ASMB) and Gilead Sciences (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised IGM Biosciences, Inc. on the transaction. IGM Biosciences, Inc. (IGM) announced the closing of its previously announced upsized underwritten public offering...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Spatial Labs on the deal. Spatial Labs, a web3 infrastructure and hardware company founded by Iddris Sandu, announced $10 million in seed funding...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Tenaya on the deal, while Davis Polk advised the joint book-running managers and representatives of the several underwriters. Clinical stage...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Inscopix on the deal. Bruker Corporation, a developer, manufacturer, and distributor of high-performance scientific instruments and analytical and diagnostic solutions,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Denali Therapeutics on the deal, while Davis Polk advised the representatives of the several underwriters. Denali Therapeutics, a biopharmaceutical company...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Enliven Therapeutics on the deal. Enliven Therapeutics, a clinical-stage precision oncology company focused on the discovery and development of next-generation small molecule kinase...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised IGM on the transaction. IGM Biosciences, Inc. announced the pricing of its underwritten public offering of 8,695,653 shares of its...
You must be a Standard 1 Year member to access this content.
